BD BRILLIANT DISTINCTIONS & Design — 1852421
Application number
1852421
Registration number
TMA1016833
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2017-08-14
Registered
2019-03-08
Registration Expiry Date
2034-03-08
Registered Owner
AbbVie Corporation
8401 TransCanada Highway
Montreal
QUEBEC H4S1Z1
Agent
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Index headings
- BD BRILLIANT DISTINCTIONS
Vienna information (Code & Description)
- 27.5.1
- Letters presenting a special form of writing
- A 27.5.22
- Monograms formed of intertwined, overlapping or otherwise combined letters
- A 27.5.19
- Letters overlapping
- 14.1.13
- Chains, links of chain
- A 14.1.15
- Links of chain
- 27.3.1
- Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object
- A 27.3.15
- Letters or numerals representing an object
- 26.4.2
- Rectangles
- A 26.4.5
- One quadrilateral
- A 26.4.18
- Quadrilaterals containing one or more letters
- A 26.4.24
- Quadrilaterals with dark surfaces or parts of surfaces
Services (Nice class & Statement)
(1) Customer incentive award program to promote customer loyalty which provides issuance, redemption and processing of loyalty points for frequent purchases of aesthetic related products
Classification data
Disclaimer
The classification data is provided for information and searching purposes only. CIPO does not warrant the accuracy of the classes assigned to the trademark. This data has no legal value of any kind.
- 35 - Advertising, marketing, promotional and business
Claims
- Used in CANADA since at least as early as November 07, 2014
Recordals (known also as Footnotes)
CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Name and Address / Nom et adresse DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2022-10-18 DATE OF CHANGE / DATE DE CHANGEMENT: 2022-07-01 COMMENTS / COMMENTAIRES: FROM/DE: Allergan Inc. TO/A: AbbVie CorporationAction History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2017-08-14 | ||
| Created | 2017-08-15 | ||
| Formalized | 2017-08-16 | ||
| Search Recorded | 2018-09-12 | ||
| Approval Notice Sent | 2018-09-12 | 2018-10-10 | |
| Approved | 2018-11-01 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2018-11-07 | Vol.65 Issue 3341 | |
| Allowance Notice Sent | 2019-02-22 | 2019-08-22 | |
| Allowed | 2019-02-22 | ||
| Registered | 2019-03-08 | 2034-03-08 | |
| Amendment to Registration | 2022-10-18 | Name and Address/Nom et address | |
| Agent Changed | 2026-04-21 | Transferred From: 2502 To: 59 |